[Code of Federal Regulations]
[Title 10, Volume 1]
[Revised as of January 1, 2001]
From the U.S. Government Printing Office via GPO Access
[CITE: 10CFR35.22]

[Page 558-559]
 
                            TITLE 10--ENERGY
 
                CHAPTER I--NUCLEAR REGULATORY COMMISSION
 
PART 35--MEDICAL USE OF BYPRODUCT MATERIAL--Table of Contents
 
             Subpart B--General Administrative Requirements
 
Sec. 35.22  Radiation Safety Committee.

    Each medical institution licensee shall establish a Radiation Safety 
Committee to oversee the use of byproduct material.
    (a) Each Committee must meet the following administrative 
requirements:
    (1) Membership must consist of at least three individuals and must 
include an authorized user of each type of use permitted by the license, 
the Radiation Safety Officer, a representative of the nursing service, 
and a representative of management who is neither an authorized user nor 
a Radiation Safety Officer. Other members may be included as the 
licensee deems appropriate.
    (2) The Committee must meet at least quarterly.
    (3) To establish a quorum and to conduct business, at least one-half 
of the Committee's membership must be present, including the Radiation 
Safety Officer and the management's representative.
    (4) The minutes of each Radiation Safety Committee meeting must 
include:
    (i) The date of the meeting;
    (ii) Members present;
    (iii) Members absent;
    (iv) Summary of deliberations and discussions;
    (v) Recommended actions and the numerical results of all ballots; 
and

[[Page 559]]

    (vi) ALARA program reviews described in Sec. 35.20(c).
    (5) The Committee must promptly provide each member with a copy of 
the meeting minutes, and retain one copy for the duration of the 
license.
    (b) To oversee the use of licensed material, the Committee must:
    (1) Review recommendations on ways to maintain individual and 
collective doses ALARA;
    (2)(i) Review, on the basis of safety and with regard to the 
training and experience standards in subpart J of this part, and approve 
or disapprove any individual who is to be listed as an authorized user, 
an authorized nuclear pharmacist, the Radiation Safety Officer, or a 
teletherapy physicist before submitting a license application or request 
for amendment or renewal; or
    (ii) Review, pursuant to Sec. 35.13 (b)(1) through (b)(4), on the 
basis of the board certification, the license, or the permit identifying 
an individual, and approve or disapprove any individual prior to 
allowing that individual to work as an authorized user or authorized 
nuclear pharmacist;
    (3) Review on the basis of safety, and approve with the advice and 
consent of the Radiation Safety Officer and the management 
representative, or disapprove minor changes in radiation safety 
procedures that are not potentially important to safety and are 
permitted under Sec. 35.31 of this part;
    (4) Review quarterly, with the assistance of the Radiation Safety 
Officer, a summary of the occupational radiation dose records of all 
personnel working with byproduct material;
    (5) Review quarterly, with the assistance of the Radiation Safety 
Officer, all incidents involving byproduct material with respect to 
cause and subsequent actions taken; and
    (6) Review annually, with the assistance of the Radiation Safety 
Officer, the radiation safety program.

[51 FR 36951, Oct. 16, 1986, as amended at 59 FR 61782, Dec. 2, 1994]